Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$200K Hold
7,108
0.07% 143
2025
Q4
$177K Hold
7,108
0.07% 145
2025
Q3
$181K Sell
7,108
-492
-6% -$12.1K 0.07% 141
2025
Q2
$184K Sell
7,600
-1,500
-16% -$35K 0.08% 143
2025
Q1
$231K Hold
9,100
0.11% 127
2024
Q4
$241K Sell
9,100
-800
-8% -$21.7K 0.11% 124
2024
Q3
$287K Sell
9,900
-270
-3% -$7.88K 0.13% 113
2024
Q2
$285K Buy
10,170
+175
+2% +$4.82K 0.14% 104
2024
Q1
$277K Hold
9,995
0.14% 113
2023
Q4
$288K Sell
9,995
-917
-8% -$27.7K 0.17% 98
2023
Q3
$362K Buy
10,912
+367
+3% +$13K 0.25% 90
2023
Q2
$387K Hold
10,545
0.26% 88
2023
Q1
$430K Sell
10,545
-1,150
-10% -$49.7K 0.28% 90
2022
Q4
$599K Buy
+11,695
New +$561K 0.34% 78

Other funds holding PFE

Centennial Bank's PFE Position: Q1 2026 in Review

Centennial Bank held its Pfizer (PFE) position steady in Q1 2026 at 7,108 shares worth $200K. The position accounts for 0.07% of the portfolio, ranked #143.

Centennial Bank first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $599K in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Centennial Bank held 7,108 shares of Pfizer worth $200K as of Q1 2026.
  • Centennial Bank left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.07% of Centennial Bank's portfolio in Q1 2026, its #143 holding.
  • Centennial Bank first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • Centennial Bank's Pfizer position peaked at $599K in Q4 2022.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Centennial Bank's 13F filing for Q1 2026, filed 6 May 2026.